The shares of the outstanding drug producer fell as much as 2 p.c in at present’s buying and selling session after the corporate obtained a warning letter from SEBI for a violation of insider buying and selling laws.
With a market capitalization of Rs 15,963.14 crore, the shares of Neuland Laboratories Ltd have been buying and selling at Rs 12,442.15 per share, growing round 0.78 p.c as in comparison with the earlier closing worth of Rs 12,540.05 apiece.
The shares of Neuland Laboratories Ltd have seen destructive motion after receiving an administrative warning letter from SEBI for a violation of insider buying and selling laws by a chosen particular person of the corporate. The corporate clarified that there is no such thing as a materials impression on its financials, operations, or different actions.
Wanting ahead to the corporate’s monetary efficiency, income decreased by 15 p.c from Rs 385 crore in Q4FY24 to Rs 328 crore in Q4FY25. Additional, throughout the identical timeframe, internet revenue decreased by 59 p.c from Rs 68 crore to Rs 28 crore.
Additionally learn: Tata Group inventory to purchase now for an upside of 35%; Really useful by Morgan Stanley and Citi
As of March 2025, a outstanding investor, Mukul Mahavir, holds 4,00,000 fairness shares, which is equal to three.12 p.c within the firm. With over 40 years of expertise, the corporate has filed 980+ DMFs globally. It presents 100+ APIs throughout 10 therapeutic areas, with 82% income from exports. It holds 72 lively US DMFs, has 1174 KL manufacturing capability, and employs 1,794 individuals, highlighting robust world presence and capabilities.
The corporate has a robust world footprint, producing 86% of its income from Europe and North America. It’s headquartered in Hyderabad with three manufacturing models. Serving over 80 international locations, it maintains a stable presence throughout APAC, MENA, LATAM, and India.
Neuland Laboratories Restricted is an India-based firm that’s engaged within the manufacturing and promoting of bulk medicine. The Firm caters to each home and worldwide markets. It manufactures lively pharmaceutical substances (APIs) and is an end-to-end resolution supplier for the pharmaceutical trade’s chemistry wants.
Written by Abhishek Singh
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/score businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of monetary losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Non-public Restricted or the creator usually are not chargeable for any losses brought about because of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
